Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.420ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.420ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.1.420SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.420NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.1.420NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.1.420ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
L.3ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
L.3ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
L.3ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
L.3ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
L.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
L.3NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
L.3NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
L.3ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.36ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.36ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.36ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.36ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.36NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.36ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.518ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.518ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.518ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.518ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.518SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.518NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.518NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.518ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.551ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
B.1.551ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.551ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.551ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
B.1.551SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.551NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
B.1.551NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
B.1.551ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
C.17ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-21402.5China
C.17ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
C.17ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
C.17ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
C.17SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
C.17NUS-CDC-N-1GACCCCAAAATCAGCGAAAT20452828728306F-20656.7US
C.17NNIID-JP-NAAATTTTGGGGACCAGGAAC20452912529144F-20489.8Japan
C.17ORF1abNIID WH-1 Seq F519R840ACCTCATGGTCATGTTATGG2045502521F-20812.9Japan
B.1.1.207ORF1abYip-ORF1abATGCATTTGCATCAGAGGCT204518661885F-2539.84China
B.1.1.207ORF1abYip-ORF1abTTGTTATAGCGGCCTTCTGT204519701951R-21075.5China
B.1.1.207ORF1abWon-ORF1abTGCATTAACATTGGCCGTGA20451555815539R-21175.8South Korea
B.1.1.207ORF1abHKU-ORF1bTGGGGYTTTACRGGTAACCT20451877818797F-7043.36Hong Kong
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used